Truist raised the firm’s price target on Charles Schwab (SCHW) to $91 from $90 and keeps a Buy rating on the shares following this morning’s ...
Truist Financial analyst Joon Lee maintained a Buy rating on Crispr Therapeutics AG (CRSP – Research Report) today. The company’s shares closed ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results
Feedback